Invariant chain expression in colon neoplasms

被引:56
作者
Jiang, Z
Xu, MZ
Savas, L
LeClair, P
Banner, BF
机构
[1] Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA
[2] Antigen Express Inc, Worcester, MA 01605 USA
[3] Univ Massachusetts, Med Ctr, Div Digest Dis & Nutr, Worcester, MA USA
关键词
invariant chain; HLA-DR; colon neoplasms;
D O I
10.1007/s004280050391
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Invariant chain (Ii) is a chaperone molecule that inhibits binding of endogenous antigens to class II molecules. High levels of Ii in cancer cells may prevent tumour antigen expression with class II and render the tumour less immunogenic. To correlate the expression of Ii and class II molecules in colon carcinomas with the density of tumour infiltrating lymphocytes (TILs), surgical specimens from a total of 48 patients with well-(WDAC), moderately (MDAC) and poorly differentiated adenocarcinomas (PDAC), adenoma with high-grade dysplasia (AdHGD) and adenomas were immunostained for Ii and class II antigen (HLA-DR). Aggregates of TILs were graded in H&E-stained sections. Normal colon epithelium was negative for Ii and HLA-DR. Invasive carcinomas showed a linear increase in the expression of Ii in the progression from low- to high-grade tumours, while there was no significant difference in HLA-DR expression across the groups. Invasive carcinomas showed a disproportionate increase in Ii over HLA-DR. Frequency of TILs showed inverse correlation with expression of Ii and tumour grade. This is the first demonstration that expression of Ii increases in the progression from low- to high-grade colon neoplasms and is most marked in the poorly differentiated carcinomas. Ii expression by carcinomas is inversely related to the frequency of TILs. The findings suggest that increased Ii renders the tumour less immunogenic and less likely to stimulate a host immune response.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 25 条
[1]
STRONG HLA-DR EXPRESSION IN LARGE-BOWEL CARCINOMAS IS ASSOCIATED WITH GOOD PROGNOSIS [J].
ANDERSEN, SN ;
ROGNUM, TO ;
LUND, E ;
MELING, GI ;
HAUGE, S .
BRITISH JOURNAL OF CANCER, 1993, 68 (01) :80-85
[2]
Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity [J].
Armstrong, TD ;
Clements, VK ;
Martin, BK ;
Ting, JPY ;
OstrandRosenberg, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) :6886-6891
[3]
Bertolino P, 1996, CRIT REV IMMUNOL, V16, P359
[4]
DIVERSITY OF ENDOGENOUS EPITOPES BOUND TO MHC CLASS-II MOLECULES LIMITED BY INVARIANT CHAIN [J].
BODMER, H ;
VIVILLE, S ;
BENOIST, C ;
MATHIS, D .
SCIENCE, 1994, 263 (5151) :1284-1286
[5]
CARBERA T, 1995, SCAND J IMMUNOL, V41, P398
[6]
Ceman S, 1995, Semin Immunol, V7, P373, DOI 10.1006/smim.1995.0042
[7]
CLEMENTS VK, 1992, J IMMUNOL, V149, P2391
[8]
DIFFERENTIAL EXPRESSION OF HLA-DR, HLA-DP, HLA-DQ AND ASSOCIATED INVARIANT CHAIN (II) IN NORMAL COLORECTAL MUCOSA, ADENOMA AND CARCINOMA [J].
DEGENER, T ;
MOMBURG, F ;
MOLLER, P .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1988, 412 (04) :315-322
[9]
DUKES CE, 1949, ANN ROY COLL SURG, V4, P90
[10]
THE SURGICAL PATHOLOGY OF RECTAL CANCER [J].
DUKES, CE .
JOURNAL OF CLINICAL PATHOLOGY, 1949, 2 (02) :95-98